Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1093/JLEUKO/QIAF011 | ||||
| Año | 2025 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Natural Killer (NK) cells are crucial in recognizing and eliminating tumor cells, making them pivotal in antitumor responses. Adenosine, the product of ATP hydrolysis mediated by CD39 and CD73 ectonucleotidases, has been reported to reduce the proliferation and maturation of NK cells. In this study, we investigate the expression of CD73 in NK cells and its impact on maturation, phenotype, survival, and function. Our findings reveal that while splenic NK cells express minimal levels of CD73, its expression is induced upon activation and in the tumor microenvironment upon adoptive transfer to tumor-bearing mice. Notably, within the tumor microenvironment, CD73 expression in NK cells correlates with elevated levels of PD-L1 and CD226. Accordingly, analysis of human melanoma datasets uncovers a subset of immature tumor-infiltrating NK cells expressing CD73. To further understand the role of CD73 on NK cells, we used a CD73 knockout (KO) murine model and observed that CD73-deficient NK cells display a more immature phenotype and heightened proliferative activity than wild-type (WT) NK cells. Additionally, CD73-deficient NK cells exhibit elevated levels of P2X7R and reduced CD39 expression, suggesting an increased susceptibility to ATP-induced death. Following adoptive transfer to tumor-bearing mice, CD73KO NK cells are present at a lower frequency but demonstrate similar control over tumor growth compared with WT NK cells. In conclusion, our study demonstrates the upregulation of CD73 in NK cells infiltrating tumors and underscores its role as a checkpoint regulating the functional maturation of NK cells.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Parra-Tello, Brian | - |
Universidad de Chile - Chile
|
| 2 | Garcia-Gomez, Moira | - |
Universidad de Chile - Chile
|
| 3 | Rekus-Polanska, Eva | - |
Universidad de Chile - Chile
|
| 4 | Malgue, Felipe | - |
Universidad de Chile - Chile
|
| 5 | Charlin, Sebastian | - |
Universidad de Chile - Chile
|
| 6 | Hernandez-Oliveras, Andres | - |
Ctr Ciencia & Vida - Chile
Universidad San Sebastián - Chile |
| 7 | Reyes-Alvarez, Javiera | - |
Ctr Ciencia & Vida - Chile
Universidad San Sebastián - Chile |
| 8 | Rosemblatt, Mario | - |
Universidad de Chile - Chile
Ctr Ciencia & Vida - Chile Universidad San Sebastián - Chile |
| 9 | Lundqvist, A. | Hombre |
Karolinska Inst - Suecia
Karolinska Institutet - Suecia |
| 10 | Lladser, Alvaro | Hombre |
Ctr Ciencia & Vida - Chile
Universidad San Sebastián - Chile |
| 11 | BONO-MERINO, MARIA ROSA | Mujer |
Universidad de Chile - Chile
Ctr Ciencia & Vida - Chile |
| 12 | SAUMA-MAHALUF, DANIELA MACARENA | Mujer |
Universidad de Chile - Chile
Ctr Ciencia & Vida - Chile |
| Fuente |
|---|
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| ANID Fondecyt |
| Agencia Nacional de Investigación y Desarrollo |
| Agencia Nacional de Investigacion y Desarrollo ANID |
| ANID/FONDEQUIP |
| ANID Master grants |
| Centro Cientifico y Tecnologico de Excelencia Ciencia |
| Centro Cientifico y Tecnologico de Excelencia Ciencia & Vida |
| Agradecimiento |
|---|
| This work was supported by Centro Cientifico y Tecnologico de Excelencia Ciencia & Vida, FB210008 from Agencia Nacional de Investigacion y Desarrollo ANID (DS, MR, AL, and MRB), ANID FONDECYT grants 1220196 (DS), 1230183 (MRB), 1212070 (AL), 3220741 (AHO), ANID Master grants 22190463 (BPT), 22221673 (MGG), 22241251 (FM), and ANID/FONDEQUIP EQM220027 (DS) and ANID/FONDEQUIP EQM140016 (MRB). |
| This work was supported by Centro Cientifico y Tecnologico de Excelencia Ciencia & Vida, FB210008 from Agencia Nacional de Investigacion y Desarrollo ANID (DS, MR, AL, and MRB), ANID FONDECYT grants 1220196 (DS), 1230183 (MRB), 1212070 (AL), 3220741 (AHO), ANID Master grants 22190463 (BPT), 22221673 (MGG), 22241251 (FM), and ANID/FONDEQUIP EQM220027 (DS) and ANID/FONDEQUIP EQM140016 (MRB). |